View in EDS

Feasibility and safety profile of high-dose oxaliplatin-based PIPAC (120mg/m2) in the treatment of advanced peritoneal metastatic disease: MINOS real-life multicenter study.

Saved in:
Bibliographic Details
Title: Feasibility and safety profile of high-dose oxaliplatin-based PIPAC (120mg/m2) in the treatment of advanced peritoneal metastatic disease: MINOS real-life multicenter study.
Authors: Zambrano DA; Department of Surgical Oncology, Institut du Cancer Montpellier, University of Montpellier, Montpellier, France; Sociedad de Lucha Contra el Cáncer SOLCA-Guayaquil, Ecuador; Universidad Espíritu Santo-Ecuador, UEES, Samborondón, Ecuador., Lintis A; University Hospital CHU Lyon Sud, Pierre-Benite, France., Kefleyesus A; University Hospital CHUV Lausanne, Lausanne, Switzerland., Taibi A; CHU Limoges, Limoges, France., Eveno C; CHU Lille, Lille, France., Pocard M; CHU Pitié-Salpêtrière, Paris, France., De Meeus G; Department of Surgical Oncology, Institut du Cancer Montpellier, University of Montpellier, Montpellier, France., Quénet F; Department of Surgical Oncology, Institut du Cancer Montpellier, University of Montpellier, Montpellier, France., Kepenekian V; University Hospital CHU Lyon Sud, Pierre-Benite, France., Hübner M; University Hospital CHUV Lausanne, Lausanne, Switzerland., Glehen O; University Hospital CHU Lyon Sud, Pierre-Benite, France., Sgarbura O; Department of Surgical Oncology, Institut du Cancer Montpellier, University of Montpellier, Montpellier, France; IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut régional du Cancer de Montpellier, Montpellier, F-34298, France. Electronic address: olivia.sgarbura@icm.unicancer.fr.
Source: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2026 May; Vol. 52 (5), pp. 111731. Date of Electronic Publication: 2026 Mar 04.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 8504356 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2157 (Electronic) Linking ISSN: 07487983 NLM ISO Abbreviation: Eur J Surg Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41830675
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Feasibility and safety profile of high-dose oxaliplatin-based PIPAC (120mg/m2) in the treatment of advanced peritoneal metastatic disease: MINOS real-life multicenter study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Zambrano+DA%22">Zambrano DA</searchLink>; Department of Surgical Oncology, Institut du Cancer Montpellier, University of Montpellier, Montpellier, France; Sociedad de Lucha Contra el Cáncer SOLCA-Guayaquil, Ecuador; Universidad Espíritu Santo-Ecuador, UEES, Samborondón, Ecuador.<br /><searchLink fieldCode="AU" term="%22Lintis+A%22">Lintis A</searchLink>; University Hospital CHU Lyon Sud, Pierre-Benite, France.<br /><searchLink fieldCode="AU" term="%22Kefleyesus+A%22">Kefleyesus A</searchLink>; University Hospital CHUV Lausanne, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Taibi+A%22">Taibi A</searchLink>; CHU Limoges, Limoges, France.<br /><searchLink fieldCode="AU" term="%22Eveno+C%22">Eveno C</searchLink>; CHU Lille, Lille, France.<br /><searchLink fieldCode="AU" term="%22Pocard+M%22">Pocard M</searchLink>; CHU Pitié-Salpêtrière, Paris, France.<br /><searchLink fieldCode="AU" term="%22De+Meeus+G%22">De Meeus G</searchLink>; Department of Surgical Oncology, Institut du Cancer Montpellier, University of Montpellier, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Quénet+F%22">Quénet F</searchLink>; Department of Surgical Oncology, Institut du Cancer Montpellier, University of Montpellier, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Kepenekian+V%22">Kepenekian V</searchLink>; University Hospital CHU Lyon Sud, Pierre-Benite, France.<br /><searchLink fieldCode="AU" term="%22Hübner+M%22">Hübner M</searchLink>; University Hospital CHUV Lausanne, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Glehen+O%22">Glehen O</searchLink>; University Hospital CHU Lyon Sud, Pierre-Benite, France.<br /><searchLink fieldCode="AU" term="%22Sgarbura+O%22">Sgarbura O</searchLink>; Department of Surgical Oncology, Institut du Cancer Montpellier, University of Montpellier, Montpellier, France; IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut régional du Cancer de Montpellier, Montpellier, F-34298, France. Electronic address: olivia.sgarbura@icm.unicancer.fr.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228504356%22">European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology</searchLink> [Eur J Surg Oncol] 2026 May; Vol. 52 (5), pp. 111731. <i>Date of Electronic Publication: </i>2026 Mar 04.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8504356 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-2157 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2207487983%22">07487983 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Surg Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41830675
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ejso.2026.111731
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 111731
    Titles:
      – TitleFull: Feasibility and safety profile of high-dose oxaliplatin-based PIPAC (120mg/m2) in the treatment of advanced peritoneal metastatic disease: MINOS real-life multicenter study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zambrano DA
      – PersonEntity:
          Name:
            NameFull: Lintis A
      – PersonEntity:
          Name:
            NameFull: Kefleyesus A
      – PersonEntity:
          Name:
            NameFull: Taibi A
      – PersonEntity:
          Name:
            NameFull: Eveno C
      – PersonEntity:
          Name:
            NameFull: Pocard M
      – PersonEntity:
          Name:
            NameFull: De Meeus G
      – PersonEntity:
          Name:
            NameFull: Quénet F
      – PersonEntity:
          Name:
            NameFull: Kepenekian V
      – PersonEntity:
          Name:
            NameFull: Hübner M
      – PersonEntity:
          Name:
            NameFull: Glehen O
      – PersonEntity:
          Name:
            NameFull: Sgarbura O
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2026 May
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1532-2157
          Numbering:
            – Type: volume
              Value: 52
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
              Type: main
ResultId 1